These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 12918234
1. [Prevention of adverse reactions of antituberculous drugs in pulmonary tuberculosis in patients with different genetic background]. Tashpulatova FK. Probl Tuberk Bolezn Legk; 2003; (6):17-20. PubMed ID: 12918234 [Abstract] [Full Text] [Related]
2. [Prevention of adverse reactions of antituberculous drugs in pulmonary tuberculosis in patients with different genetic background]. Tashpulatova FK. Probl Tuberk Bolezn Legk; 2003; (5):50-1. PubMed ID: 12899021 [Abstract] [Full Text] [Related]
3. [Incidence and pattern of recurrent side effects in persons with different haptoglobin phenotypes during chemotherapy of pulmonary tuberculosis]. Ubaĭdullaev AM, Tashpulatova FK, Kazakov KS. Probl Tuberk; 1998; (4):23-4. PubMed ID: 9771032 [Abstract] [Full Text] [Related]
4. [Frequency and pattern of adverse reactions due to treatment of patients with pulmonary tuberculosis with antitubercular reserve drugs]. Chukanov VI, Kaminskaia GO, Livchane E. Probl Tuberk Bolezn Legk; 2004; (10):6-10. PubMed ID: 15568310 [Abstract] [Full Text] [Related]
5. [The results of treating fibrous-cavernous tuberculosis in patients with different genetic markers]. Khomenko AG, Sadykov AS. Ter Arkh; 1990; 62(11):53-6. PubMed ID: 2094991 [Abstract] [Full Text] [Related]
6. [Adverse reactions of antituberculous agents, especially about its onset and duration]. Yamada H, Yasuoka A, Sasayama K, Doutsu Y, Hayashi T, Kohno S, Yamaguchi K, Hirota M, Hara K. Kekkaku; 1990 Sep; 65(9):563-8. PubMed ID: 2232434 [Abstract] [Full Text] [Related]
7. [Enhancing the effectiveness of chemotherapy for pulmonary tuberculosis by phytotherapy in patients with different genetic markers]. Tashpulatova FK, Ubaĭdullaev AM. Probl Tuberk; 2002 Sep; (12):46-9. PubMed ID: 12611337 [No Abstract] [Full Text] [Related]
8. [Incidence of adverse reactions to chemotherapy and their types in adolescents with tuberculosis]. Panova LV, Ovsiankina ES. Probl Tuberk; 2003 Sep; (1):28-30. PubMed ID: 12652980 [Abstract] [Full Text] [Related]
9. [Effectiveness of lymphotropic therapy in patients with tuberculosis in relations to genetic markers]. Ubaĭdullaev AM, Belotserkovets VG, Kazakov KS. Probl Tuberk; 2000 Sep; (6):44-6. PubMed ID: 11210834 [Abstract] [Full Text] [Related]
10. [Influence of adverse reactions due to chemotherapy on life quality indices in patients with infiltrative pulmonary tuberculosis]. Mordyk AV, Antropova VV. Probl Tuberk Bolezn Legk; 2008 Sep; (9):44-6. PubMed ID: 19065734 [Abstract] [Full Text] [Related]
11. [Changes in the patients' mental status in the tolerability of antituberculous drugs]. Mordyk AV, Briukhanova NS, Kazakov AV. Probl Tuberk Bolezn Legk; 2009 Sep; (3):38-42. PubMed ID: 19455986 [Abstract] [Full Text] [Related]
12. [Development of antituberculous drugs: current status and future prospects]. Tomioka H, Namba K. Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [Abstract] [Full Text] [Related]
13. [Biochemical bases of adverse reactions to antibacterial preparations used in renal tuberculosis and means of their prevention]. Kazakov KS, Chernik RB, Krivtsova MA. Probl Tuberk; 1989 Dec; (6):52-5. PubMed ID: 2771913 [Abstract] [Full Text] [Related]
14. [Course of infiltrating pulmonary tuberculosis depending on the patient's genotype]. Fedoseeva SV, Iusopova MM, Chukanova VP, Pospelov LE. Probl Tuberk; 1993 Dec; (2):8-10. PubMed ID: 7984577 [Abstract] [Full Text] [Related]